Day: 6 June 2016

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115916. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. This website reflects only the authors' view and the European Commission is not responsible for any use that may be made of the information it contains.